WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Julia N. Zhao et al.|Nature Cancer|2023Cited by 27
An Antagonist of KSR1‐Driven Adaptive Resistance to Clinical RAS‐MAPK InhibitorsArthur Chow, Arvin C. Dar, Jayasudhan R. Yerabolu et al.|The FASEB Journal|2022Cited by 0